![](/img/cover-not-exists.png)
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
Igor S. Lukashevich, Ricardo Carrion Jr., Maria S. Salvato, Keith Mansfield, Kathleen Brasky, Juan Zapata, Cristiana Cairo, Marco Goicochea, Gia E. Hoosien, Anysha Ticer, Joseph Bryant, Harry Davis, RVolume:
26
Year:
2008
Language:
english
DOI:
10.1016/j.vaccine.2008.07.057
File:
PDF, 943 KB
english, 2008